Ahead Therapeutics – In the News
19th October 2019
Ahead Therapeutics has reached an agreement with Dr. Rozen Le Panse from the Institute of Myology from Paris to stride forward with the preclinical development of AT_1616.
The agreement will allow Ahead Therapeutics to validate the platform potential of the PS-Liposomes using a Myasthenia Gravis in vivo...
Read More
7th August 2019
New clean room facility for R&D liposome batch production
Ahead Therapeutics has set up a clean room facility in l'Arboç (Tarragona) to be able to produce in-house, the liposome...
Read More
12th June 2019
Ahead Therapeutics has closed an agreement with Dr. med. Ribes-Koninck from La Fe Hospital & Research institute to perform ex-vivo assays with CD patients’ samples.
Ahead Therapeutics will verify the platform potential of its PS-Liposomes with blood samples coming from Celiac Disease’s patients. Researchers from...
Read More